Opposing Activities of Chromatin Modifiers in Balancing Stem Cell Division, Differentiation, and Death
Jamy Peng, Ph.D.
Associate Member
Department of Developmental Neurobiology
Comprehensive Cancer Care Center
St. Jude Children's Research Hospital
Pioneers in Biomedical Research Seminar: Opposing Activities of Chromatin Modifiers in Balancing Stem Cell Division, Differentiation, and Death
Date: Oct. 7, 2022
Time: 11 a.m. - 12 p.m.
About this Seminar
Neural stem cell division, neurogenesis, and gliogenesis give rise to all cells in the brain. Dr. Peng's lab studies the modifiers of histone H3 lysine 27 (H3K27), which regulate genetic programs for neural stem cell amplification and differentiation. Dysfunction in H3K27 modifiers lead to developmental disorders and pediatric brain tumors. The lab has uncovered regulators of these H3K27 modifiers that control stem cell division, differentiation, and death. These advances illuminate epigenetic regulation of neural stem cells and pathogenic mechanisms in brain defects and malignancy.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home ItemBiobehavioral Susceptibility for Obesity: Behavioral, Genetic and Neuroimaging Studies of Appetite , home
Sept. 6, 2024, 11:00 a.m. | Susan Carnell, Ph.D., Associate Professor, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Center for Health Behaviors Research and the Addiction Recovery Research Center, Fralin Biomedical Research Institute
-
Home ItemDevelopment of Genome Editor Therapies for Angelman Syndrome , home
Sept. 13, 2024, 11:00 a.m. | Mark J. Zylka, Ph.D., W.R. Kenan, Jr. Distinguished Professor, University of North Carolina at Chapel Hill; Director, UNC Neuroscience Center | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home ItemUnderstanding the Limits of Exercise Responsiveness in Older Adults , home
Sept. 20, 2024, 11:00 a.m. | Ian R. Lanza, Ph.D., Professor of Medicine, Mayo Clinic College of Medicine and Science | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home ItemFrom Variant Functionality to Resistance in Cancer , home
Sept. 27, 2024, 11:00 a.m. | Tiki Hayes, Ph.D., Assistant Professor, Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.
-
Home ItemDisrupting Health Care Using Deep Data and Remote Monitoring , home
Oct. 4, 2024, 11:00 a.m. | Michael Snyder, Ph.D., Professor, Genetics, Director, Center for Genomics and Personalized Medicine, Stanford Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemMechanisms of Longevity: From Mice to Whales , home
Oct. 10, 2024, 5:30 p.m. (Reception at 5 p.m.) | Vera Gorbunova, Ph.D., Doris Johns Cherry Professor of Biology, Co-director, Rochester Aging Research Center, University of Rochester | Maury Strauss Distinguished Public Lecture